We are proud to present our upcoming research showcase where our panel of experts, all thought leaders in their respective areas, will explore the role of bioengineering and advancements in technology, artificial intelligence and big data in the delivery of effective medical solutions in view of the shift towards value-based healthcare.
A selection of UNSW’s finest academics will showcase their extensive range of expertise and capability providing insight into future thinking and practice on how best to empower individuals with tools to prevent and manage health issues while addressing the challenges presented by an aging population and the opportunities available through an increasingly connected healthcare ecosystem.
Why attend?
Connect with our experts, and discuss research capability, professional education and institutional strengthening in areas including:
Who should attend?
This event is free to attend for professionals in medicine, healthcare and related industries as well as government and NGOs working in this space, or anyone who is interested in the latest thinking in these fields.
Details
Light refreshments will be served upon arrival and during the following networking session.
4.00pm Registration
4.30pm Welcome
4.45pm Panel Discussion + Q&A
5.30pm Showcase Poster Session + Networking
7.00pm Event Close
Panel Members + Moderator
• Lorraine Chiroiu, Chief Executive Officer, AusBiotech Ltd.
• Kathy Connell, Senior Director Global Innovation, Johnson & Johnson
• Scientia Professor Nigel Lovell, Head of the Graduate School of Biomedical Engineering, UNSW
• Stephen Thompson, Managing Director, Brandon Capitol Partners
• Dr Sze-Yuan Ooi, Cardiology Specialist, Prince of Wales Hospital
• Professor Anne Simmons AM, UNSW Provost - Panel Moderator
Lorraine leads AusBiotech as its Chief Executive Officer and managing director and has worked as a dedicated advocate for the biotechnology sector since joining AusBiotech over a decade ago. In this role she works closely with public policy impacting the life sciences sector at state and Federal levels, including economic development, tax incentives, patent protection, medical research and its commercialisation. Lorraine works with the broad biotechnology community and AusBiotech’s 3,000 members to inform and support industry development and has previously held the roles of Deputy CEO, Chief Industry Affairs Officer and National Communications and Media Manager at AusBiotech. Prior to joining AusBiotech, Lorraine has worked in corporate and public affairs roles for a multinational biopharmaceutical company, the Pharmacy Guild of Australia, the University of Melbourne and for a (mental) health consumer organisation as an advocate. She currently sits on the Research and Development Tax Incentive Roundtable, the CSIRO Manufacturing Business Unit Advisory Committee, the International Council of Biotechnology Associations, the Federal Government’s Clinical Trials Collaborative Forum and the Global Talent Scheme (GTS) start-up advisory panel, the University of Melbourne’s Master of Biotechnology Advisory Group, is a Director of the Agricultural Biotechnology Council of Australia, Deputy-Chair of the Australia China Business Council’s (VIC) Health and Medical Research Committee, on the Early Phase Clinical Trials Oversight Committee for NSW Health
Kathy is Senior Director of New Ventures, Australia and New Zealand (ANZ) for Johnson & Johnson Innovation, California and is responsible for implementing our strategy across Australia and New Zealand. Kathy has a clinical background and started her commercial career as the VP of Global Business Development for an Australian biotechnology company. Prior to joining Janssen, Kathy worked for Sanofi engaged in in-licensing late stage pharmaceutical assets. Kathy joined Janssen as Biotechnology Alliance Manager in 2011. Kathy is a registered psychologist and holds Post Graduate Diplomas in Health and Medical Law from the University of Melbourne, Psychology from Monash University and Bachelor degrees in Psychology (Swinburne University) and Applied Science from LaTrobe University.
Nigel is a UNSW Scientia Professor and Head of the Graduate School of Biomedical Engineering, UNSW, working in the areas of bionics, biomonitoring and physiological modelling. His research and development work has covered areas of expertise ranging from web-enabling technologies, telehealth apps, biomedical instrumentation, biological signal processing and health data analytics, neurophysiology and physiological modelling. His principal research interests have been focused in the application of appropriate technology in primary health care and design of a bionic eye. He is a board member of the journal 'Physiological Measurement', a founding board member of the 'Journal of Neural Engineering' and an Associate Editor of 'IEEE journal of Biomedical and Health Informatics'. For 2017-2018 he was President of the Institution of Electrical and Electronic Engineers (IEEE) Engineering in Medicine and Biology Society (EMBS) which is the world's largest member-based biomedical engineering professional organisation. He is a Fellow of seven learned academies throughout the world and has been awarded over $80 million in research, consultancy and infrastructure funding in his career.
Stephen is a founding partner of Brandon Capital Partners. Previously Stephen worked with Bio Innovation SA and helped establish Terra Rossa Capital. Prior to this Stephen was a Director of Apax Partners, a leading international private equity group based in London. Before joining Apax Partners, he fulfilled roles in product development with UK biotechnology company Cantab Pharmaceuticals. Earlier, Stephen spent ten years as a research immunologist in London and California. Stephen is a Director of Auspherix Ltd, Elastagen P/L, OncoRes Medical P/L, Vaxxas P/L and a Director of the Australian Venture Capital Association Limited (AVCAL). Stephen has an Honours degree in Immunology and Biochemistry, a PhD in Immunology from Kings College London and an MBA, specialising in Entrepreneurship, from Imperial College London. Stephen is a Graduate of the Australian Institute of Company Directors and a member of AusBiotech.
Dr Sze-Yuan Ooi is a Fellow of the Australasian College of Physicians (FRACP) and the Cardiac Society of Australia and New Zealand (FCSANZ). Dr Ooi held the position of Research Fellow in Cardiology at the Institute for Cardiovascular Research in Leeds, England from 2003 to 2005. He was the recipient of the Wilcken-McCredie Travelling Fellowship in 2002 and the Stanley Taylor Foundation Research Grant in 2003. He was awarded a Doctorate in Medicine with Commendation through the University of Leeds in 2008 for his thesis, “The role of cytokines in the pathogenesis of the acute coronary syndrome”. Dr Ooi held the position of Network Director of Physician Training, East Coast Medical Network from 2009 to 2012. He currently holds a Staff Specialist position in Cardiology, Prince of Wales Hospital and a Conjoint Senior Lecturer appointment through the University of New South Wales.
Anne has served in senior leadership roles in Australian higher education for 20 years. As UNSW Provost, she is the senior deputy to the Vice-Chancellor and a member of the University’s Management Board. Professor Simmons has had an outstanding track record of leadership at the University. She has been the head of two schools in the Faculty of Engineering: the Graduate School of Biomedical Engineering and the School of Mechanical and Manufacturing Engineering. In addition to her university leadership career, Professor Simmons has had a successful career in industry with the Nucleus Group, which included Telectronics and Cochlear. Her research activities have spanned biomaterials, sterilisation of medical devices and the analysis of complex blood flows. She has led programs of industry-based research relating to the development of blood contacting materials and devices. Professor Simmons has also taught courses in innovation, commercialisation and regulatory affairs in biomedical technology. She chairs the Australian government’s Advisory Committee on Medical Devices and is a member of other national committees involved in the medical technology area. She is a Fellow of the Institute of Engineers Australia, a Fellow of the Australian Academy of Technology and Engineering and was made a Member of the Order of Australia (AM) for services to biomedical engineering in 2013.
